Sinomab Bioscience posts HY loss of RMB127.4 million
Sinomab Bioscience reported a HY loss of RMB127.4 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Sinomab Bioscience reported a HY loss of RMB127.4 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.